These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21366806)

  • 1. Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile.
    Chen Y; Bogosavljevic V; Leys D; Jovanovic D; Beslac-Bumbasirevic L; Lucas C
    Eur J Neurol; 2011 Oct; 18(10):1246-50. PubMed ID: 21366806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.
    Brunser AM; Illanes S; Lavados PM; Muñoz P; Cárcamo D; Hoppe A; Olavarria VV; Delgado I; Díaz V
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1140-5. PubMed ID: 23253534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for acute cerebral ischemia in Belgrade, Serbia: comparison with Lille, France.
    Bogosavljevic V; Bodenant M; Beslac-Bumbasirevic L; Cordonnier C; Jovanovic DR; Budimkic M; Leys D
    Eur Neurol; 2011; 66(1):30-6. PubMed ID: 21709419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience.
    Lewandowski C; Mays-Wilson K; Miller J; Penstone P; Miller DJ; Bakoulas K; Mitsias P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):48-52. PubMed ID: 25440358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can rt-PA be administered to the wrong patient? Two patients with somatoform disorder.
    Mouradian MS; Rodgers J; Kashmere J; Jickling G; McCombe J; Emery DJ; Demchuk AM; Shuaib A
    Can J Neurol Sci; 2004 Feb; 31(1):99-101. PubMed ID: 15038478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.
    Bodenant M; Leys D; Debette S; Cordonnier C; Dumont F; Hénon H; Girot M; Lucas C; Devos D; Defebvre L; Deplanque D; Leclerc X; Bordet R
    Cerebrovasc Dis; 2010; 30(2):148-56. PubMed ID: 20551630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
    Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
    Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.